The Manufacturers Life Insurance Company grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 5.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,553 shares of the medical instruments supplier's stock after buying an additional 1,259 shares during the period. The Manufacturers Life Insurance Company owned 0.11% of Mettler-Toledo International worth $27,814,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in the stock. WPG Advisers LLC acquired a new stake in Mettler-Toledo International during the 1st quarter valued at approximately $41,000. Zions Bancorporation National Association UT acquired a new stake in shares of Mettler-Toledo International during the first quarter worth $43,000. Golden State Wealth Management LLC raised its stake in Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after buying an additional 35 shares during the last quarter. Menard Financial Group LLC acquired a new position in Mettler-Toledo International in the fourth quarter valued at $67,000. Finally, Blue Trust Inc. lifted its holdings in Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after buying an additional 52 shares during the period. 95.07% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, insider Gerry Keller sold 165 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock worth $2,371,208 in the last quarter. Corporate insiders own 1.94% of the company's stock.
Mettler-Toledo International Stock Up 1.3%
Shares of NYSE:MTD traded up $16.86 during trading on Friday, hitting $1,304.65. The stock had a trading volume of 95,040 shares, compared to its average volume of 171,187. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01. The company has a market capitalization of $26.87 billion, a PE ratio of 33.04, a PEG ratio of 3.81 and a beta of 1.37. The firm's fifty day moving average is $1,248.77 and its 200 day moving average is $1,186.66.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the previous year, the firm posted $9.65 earnings per share. Mettler-Toledo International's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.
Analysts Set New Price Targets
Several research analysts have recently weighed in on MTD shares. Barclays initiated coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective for the company. Robert W. Baird increased their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price objective for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Evercore ISI lowered their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research report on Monday, August 4th. Finally, Citigroup lifted their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $1,311.11.
Get Our Latest Stock Report on MTD
Mettler-Toledo International Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Recommended Stories

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report